These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 38023171)
1. Advances in the relationship between ferroptosis and epithelial-mesenchymal transition in cancer. Mu W; Zhou Z; Shao L; Wang Q; Feng W; Tang Y; He Y; Wang Y Front Oncol; 2023; 13():1257985. PubMed ID: 38023171 [TBL] [Abstract][Full Text] [Related]
2. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy. Ebrahimi N; Adelian S; Shakerian S; Afshinpour M; Chaleshtori SR; Rostami N; Rezaei-Tazangi F; Beiranvand S; Hamblin MR; Aref AR Cytokine Growth Factor Rev; 2022 Apr; 64():33-45. PubMed ID: 35219587 [TBL] [Abstract][Full Text] [Related]
3. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance. Ren Y; Mao X; Xu H; Dang Q; Weng S; Zhang Y; Chen S; Liu S; Ba Y; Zhou Z; Han X; Liu Z; Zhang G Cell Mol Life Sci; 2023 Aug; 80(9):263. PubMed ID: 37598126 [TBL] [Abstract][Full Text] [Related]
4. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay. Zhang H; Chen N; Ding C; Zhang H; Liu D; Liu S Front Oncol; 2024; 14():1344290. PubMed ID: 38469234 [TBL] [Abstract][Full Text] [Related]
5. d-Borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy. Li J; Yuan J; Li Y; Wang J; Xie Q; Ma R; Wang J; Ren M; Lu D; Xu Z Phytomedicine; 2022 Nov; 106():154411. PubMed ID: 36030746 [TBL] [Abstract][Full Text] [Related]
6. The transcription factor BACH1 at the crossroads of cancer biology: From epithelial-mesenchymal transition to ferroptosis. Igarashi K; Nishizawa H; Saiki Y; Matsumoto M J Biol Chem; 2021 Sep; 297(3):101032. PubMed ID: 34339740 [TBL] [Abstract][Full Text] [Related]
7. HDAC inhibition induces EMT and alterations in cellular iron homeostasis to augment ferroptosis sensitivity in SW13 cells. Oliveira T; Hermann E; Lin D; Chowanadisai W; Hull E; Montgomery M Redox Biol; 2021 Nov; 47():102149. PubMed ID: 34600336 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer. Lee J; You JH; Kim MS; Roh JL Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720 [TBL] [Abstract][Full Text] [Related]
9. Role of Ferroptosis in Regulating the Epithelial-Mesenchymal Transition in Pulmonary Fibrosis. Ling H; Xiao H; Luo T; Lin H; Deng J Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672671 [TBL] [Abstract][Full Text] [Related]
10. Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer. Liu X; Zhang Y; Wu X; Xu F; Ma H; Wu M; Xia Y Front Pharmacol; 2022; 13():909821. PubMed ID: 35847022 [TBL] [Abstract][Full Text] [Related]
11. Eriocitrin inhibits epithelial-mesenchymal transformation (EMT) in lung adenocarcinoma cells via triggering ferroptosis. Gao M; Lai K; Deng Y; Lu Z; Song C; Wang W; Xu C; Li N; Geng Q Aging (Albany NY); 2023 Oct; 15(19):10089-10104. PubMed ID: 37787987 [TBL] [Abstract][Full Text] [Related]
12. Ferroptosis in Cancer Progression. Zhang R; Chen J; Wang S; Zhang W; Zheng Q; Cai R Cells; 2023 Jul; 12(14):. PubMed ID: 37508485 [TBL] [Abstract][Full Text] [Related]
13. Single-Cell RNA-Seq Reveals the Promoting Role of Ferroptosis Tendency During Lung Adenocarcinoma EMT Progression. Yao J; Zhang Y; Li M; Sun Z; Liu T; Zhao M; Li Z Front Cell Dev Biol; 2021; 9():822315. PubMed ID: 35127731 [TBL] [Abstract][Full Text] [Related]
14. NF- Zhou Y; Qian W; Li X; Wei W Oxid Med Cell Longev; 2023; 2023():7098313. PubMed ID: 36699318 [TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition: a hallmark in pancreatic cancer stem cell migration, metastasis formation, and drug resistance. Safa AR J Cancer Metastasis Treat; 2020; 6():. PubMed ID: 34841087 [TBL] [Abstract][Full Text] [Related]
16. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance. Palamaris K; Felekouras E; Sakellariou S Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771695 [TBL] [Abstract][Full Text] [Related]
17. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771 [No Abstract] [Full Text] [Related]
18. Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds. Ang HL; Mohan CD; Shanmugam MK; Leong HC; Makvandi P; Rangappa KS; Bishayee A; Kumar AP; Sethi G Med Res Rev; 2023 Jul; 43(4):1141-1200. PubMed ID: 36929669 [TBL] [Abstract][Full Text] [Related]
19. Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative review. Cai Y; Wang B; Li B; Huang X; Guo H; Liu Y; Chen B; Zhao S; Wu S; Li W; Wang L; Jia K; Wang H; Chen P; Jiang M; Tang X; Qi H; Dai C; Ye J; He Y Ann Transl Med; 2021 Jun; 9(11):946. PubMed ID: 34350261 [TBL] [Abstract][Full Text] [Related]
20. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. Chen HT; Liu H; Mao MJ; Tan Y; Mo XQ; Meng XJ; Cao MT; Zhong CY; Liu Y; Shan H; Jiang GM Mol Cancer; 2019 May; 18(1):101. PubMed ID: 31126310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]